Based on the Nutex Health Inc stock forecast from 2 analysts, the average analyst target price for Nutex Health Inc is USD 50.00 over the next 12 months. Nutex Health Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Nutex Health Inc is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, Nutex Health Inc’s stock price was USD 31.33. Nutex Health Inc’s stock price has changed by +8.45% over the past week, +62.33% over the past month and -11.08% over the last year.
No recent analyst target price found for Nutex Health Inc
No recent average analyst rating found for Nutex Health Inc
Company Overview Nutex Health Inc
Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas. Read Less
Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a...Read More
Frequently Asked Questions About Nutex Health Inc (NUTX) Stock
Based on ratings from 2 analysts Nutex Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 4 buy, sell and hold ratings.
Unfortunately we do not have enough data on NUTX's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for NUTX is USD 50.00 over the next 12 months. The maximum analyst target price is USD 60 while the minimum anlayst target price is USD 45.
NUTX stock's Price/Earning ratio is 1.20.
Our analysis grades NUTX stock's Price / Earning ratio at A. This means that NUTX stock's Price/Earning ratio is above 6.999999999999995% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this NUTX may be undervalued for its sector.
The last closing price of NUTX's stock was USD 31.33.
The most recent market capitalization for NUTX is USD 0.11B.
Based on targets from 2 analysts, the average taret price for NUTX is projected at USD 50.00 over the next 12 months.
This means that NUTX's stock price may go up by +59.59% over the next 12 months.
We can't find any ETFs which contains Nutex Health Inc's stock.
As per our most recent records Nutex Health Inc has 800 Employees.
Nutex Health Inc's registered address is 6030 South Rice Avenue, Houston, TX, United States, 77081.
You can get more information about it from Nutex Health Inc's website at https://www.nutexhealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Nutex Health Inc (NUTX) Stock
Based on ratings from 2 analysts Nutex Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 4 buy, sell and hold ratings.
Unfortunately we do not have enough data on NUTX's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for NUTX is USD 50.00 over the next 12 months. The maximum analyst target price is USD 60 while the minimum anlayst target price is USD 45.
NUTX stock's Price/Earning ratio is 1.20.
Our analysis grades NUTX stock's Price / Earning ratio at A. This means that NUTX stock's Price/Earning ratio is above 6.999999999999995% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this NUTX may be undervalued for its sector.
The last closing price of NUTX's stock was USD 31.33.
The most recent market capitalization for NUTX is USD 0.11B.
Based on targets from 2 analysts, the average taret price for NUTX is projected at USD 50.00 over the next 12 months.
This means that NUTX's stock price may go up by +59.59% over the next 12 months.
We can't find any ETFs which contains Nutex Health Inc's stock.
As per our most recent records Nutex Health Inc has 800 Employees.
Nutex Health Inc's registered address is 6030 South Rice Avenue, Houston, TX, United States, 77081.
You can get more information about it from Nutex Health Inc's website at https://www.nutexhealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NUTX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
